GB9205917D0 - Pharmaceuticals - Google Patents
PharmaceuticalsInfo
- Publication number
- GB9205917D0 GB9205917D0 GB929205917A GB9205917A GB9205917D0 GB 9205917 D0 GB9205917 D0 GB 9205917D0 GB 929205917 A GB929205917 A GB 929205917A GB 9205917 A GB9205917 A GB 9205917A GB 9205917 D0 GB9205917 D0 GB 9205917D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- pharmaceuticals
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929205917A GB9205917D0 (en) | 1992-03-18 | 1992-03-18 | Pharmaceuticals |
KR1019940703269A KR950701638A (en) | 1992-03-18 | 1993-03-18 | Antiviral phosphonic acid derivatives of purine analogues |
AU37607/93A AU3760793A (en) | 1992-03-18 | 1993-03-18 | Antiviral phosphonic acid derivatives of purine analogues |
JP5516084A JPH07504666A (en) | 1992-03-18 | 1993-03-18 | Antiviral phosphonic acid derivatives of purine analogs |
EP93906699A EP0631583A1 (en) | 1992-03-18 | 1993-03-18 | Antiviral phosphonic acid derivatives of purine analogues |
PCT/GB1993/000560 WO1993019075A1 (en) | 1992-03-18 | 1993-03-18 | Antiviral phosphonic acid derivatives of purine analogues |
CA002132303A CA2132303A1 (en) | 1992-03-18 | 1993-03-18 | Antiviral phosphonic acid derivatives of purine analogues |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929205917A GB9205917D0 (en) | 1992-03-18 | 1992-03-18 | Pharmaceuticals |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9205917D0 true GB9205917D0 (en) | 1992-04-29 |
Family
ID=10712396
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB929205917A Pending GB9205917D0 (en) | 1992-03-18 | 1992-03-18 | Pharmaceuticals |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0631583A1 (en) |
JP (1) | JPH07504666A (en) |
KR (1) | KR950701638A (en) |
AU (1) | AU3760793A (en) |
CA (1) | CA2132303A1 (en) |
GB (1) | GB9205917D0 (en) |
WO (1) | WO1993019075A1 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2485597C (en) | 2002-05-13 | 2013-07-02 | Metabasis Therapeutics, Inc. | Process for preparation of cyclic prodrugs of pmea and pmpa |
WO2004037161A2 (en) | 2002-05-13 | 2004-05-06 | Metabasis Therapeutics, Inc. | Cyclic prodrugs of pmea one of its analogues |
RU2006138907A (en) | 2004-06-08 | 2008-07-20 | Метабазис Терапеутикс | SYNTHESIS OF COMPLEX CYCLIC ETHERS USING LEWIS ACID |
ES2401285T3 (en) | 2004-12-16 | 2013-04-18 | The Regents Of The University Of California | Drugs with lung as target |
ES2874774T3 (en) | 2011-12-22 | 2021-11-05 | Geron Corp | Guanine Analogs as Telomerase Substrates and Telomere Length Affects |
CN103665043B (en) | 2012-08-30 | 2017-11-10 | 江苏豪森药业集团有限公司 | A kind of tenofovir prodrug and its application in medicine |
SI2970346T1 (en) | 2013-03-15 | 2018-12-31 | The Regents Of The University Of California | Acyclic nucleoside phosphonate diesters |
AU2015217221A1 (en) | 2014-02-13 | 2016-08-11 | Ligand Pharmaceuticals, Inc. | Prodrug compounds and their uses |
JP2017520545A (en) | 2014-07-02 | 2017-07-27 | リガンド・ファーマシューティカルズ・インコーポレイテッド | Prodrug compounds and their use |
JP6708329B2 (en) | 2014-09-15 | 2020-06-10 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | Nucleotide analogues |
US10377782B2 (en) | 2015-09-15 | 2019-08-13 | The Regents Of The University Of California | Nucleotide analogs |
WO2019139919A1 (en) | 2018-01-09 | 2019-07-18 | Ligand Pharmaceuticals, Inc. | Acetal compounds and therapeutic uses thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL160927B1 (en) * | 1987-11-30 | 1993-05-31 | Beecham Group Plc | Method for manufacturing new derivatives of purine |
EP0353955A3 (en) * | 1988-08-02 | 1991-08-14 | Beecham Group Plc | Novel compounds |
GB8912043D0 (en) * | 1989-05-25 | 1989-07-12 | Beecham Group Plc | Novel compounds |
ATE167679T1 (en) * | 1990-09-14 | 1998-07-15 | Acad Of Science Czech Republic | PHOSPHONATE PRECURSORS |
-
1992
- 1992-03-18 GB GB929205917A patent/GB9205917D0/en active Pending
-
1993
- 1993-03-18 WO PCT/GB1993/000560 patent/WO1993019075A1/en not_active Application Discontinuation
- 1993-03-18 EP EP93906699A patent/EP0631583A1/en not_active Withdrawn
- 1993-03-18 CA CA002132303A patent/CA2132303A1/en not_active Abandoned
- 1993-03-18 JP JP5516084A patent/JPH07504666A/en active Pending
- 1993-03-18 AU AU37607/93A patent/AU3760793A/en not_active Abandoned
- 1993-03-18 KR KR1019940703269A patent/KR950701638A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO1993019075A1 (en) | 1993-09-30 |
JPH07504666A (en) | 1995-05-25 |
AU3760793A (en) | 1993-10-21 |
EP0631583A1 (en) | 1995-01-04 |
CA2132303A1 (en) | 1993-09-30 |
KR950701638A (en) | 1995-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP9300494A0 (en) | Pharmaceuticals | |
GB9221468D0 (en) | Pharmaceuticals | |
GB9204565D0 (en) | Pharmaceuticals | |
GB9219163D0 (en) | Pharmaceuticals | |
GB9205917D0 (en) | Pharmaceuticals | |
GB9214184D0 (en) | Pharmaceuticals | |
GB9201961D0 (en) | Pharmaceuticals | |
GB9220585D0 (en) | Pharmaceuticals | |
GB9208321D0 (en) | Pharmaceuticals | |
GB9205427D0 (en) | Pharmaceuticals | |
GB9216906D0 (en) | Pharmaceuticals | |
GB9205365D0 (en) | Pharmaceuticals | |
GB9220508D0 (en) | Pharmaceuticals | |
GB9205428D0 (en) | Pharmaceuticals | |
GB9203977D0 (en) | Pharmaceuticals | |
GB9205918D0 (en) | Pharmaceuticals | |
GB9206075D0 (en) | Pharmaceuticals | |
GB9207414D0 (en) | Pharmaceuticals | |
GB9207820D0 (en) | Pharmaceuticals | |
GB9202510D0 (en) | Pharmaceuticals | |
GB9208434D0 (en) | Pharmaceuticals | |
GB9211072D0 (en) | Pharmaceuticals | |
GB9211082D0 (en) | Pharmaceuticals | |
GB9211925D0 (en) | Pharmaceuticals | |
GB9211926D0 (en) | Pharmaceuticals |